Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
3
×
clinical trials
3
×
detroit blog main
detroit top stories
fda
incyte
3
×
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alzheimer's disease
cancer immunotherapy
crispr-cas9
deals
eidos therapeutics
eli lilly
europe blog main
europe top stories
What
roundup
bio
days
ahead
alliance
ambien
american
annual
asco
attendees
attention
biotech
black
bristol
buy
calls
camp’s
cancer
cash
changing
chicago
city
clinical
color
combinations
community’s
companies
continue
crispr
debut
diamond
diamond’s
drug
expanding
focus
growing
home
hours
indication
key
Language
unset
Current search:
incyte
×
cancer
×
" clinical trials "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More